Security & Protection Services
Compare Stocks
5 / 10Stock Comparison
GFAI vs BCO vs VRRM vs ARMK vs ALLE
Revenue, margins, valuation, and 5-year total return — side by side.
Security & Protection Services
Information Technology Services
Specialty Business Services
Security & Protection Services
GFAI vs BCO vs VRRM vs ARMK vs ALLE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Security & Protection Services | Security & Protection Services | Information Technology Services | Specialty Business Services | Security & Protection Services |
| Market Cap | $10M | $4.44B | $2.22B | $11.84B | $11.76B |
| Revenue (TTM) | $72M | $5.39B | $979M | $18.79B | $4.16B |
| Net Income (TTM) | $-24M | $180M | $131M | $317M | $634M |
| Gross Margin | 15.1% | 26.1% | 97.5% | 7.0% | 45.0% |
| Operating Margin | -27.4% | 10.7% | 23.8% | 4.2% | 20.6% |
| Forward P/E | — | 11.7x | 10.8x | 20.3x | 15.6x |
| Total Debt | $3M | $4.93B | $38M | $5.72B | $2.28B |
| Cash & Equiv. | $22M | $2.27B | $65M | $639M | $356M |
GFAI vs BCO vs VRRM vs ARMK vs ALLE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jan 21 | May 26 | Return |
|---|---|---|---|
| Guardforce AI Co., … (GFAI) | 100 | 0.5 | -99.5% |
| The Brink's Company (BCO) | 100 | 158.2 | +58.2% |
| Verra Mobility Corp… (VRRM) | 100 | 114.3 | +14.3% |
| Aramark (ARMK) | 100 | 182.1 | +82.1% |
| Allegion plc (ALLE) | 100 | 127.8 | +27.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: GFAI vs BCO vs VRRM vs ARMK vs ALLE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
GFAI lags the leaders in this set but could rank higher in a more targeted comparison.
BCO is the #2 pick in this set and the best alternative if long-term compounding and valuation efficiency is your priority.
- 293.0% 10Y total return vs ARMK's 97.1%
- PEG 0.20 vs ALLE's 0.92
- Lower P/E (11.7x vs 15.6x), PEG 0.20 vs 0.92
- +19.4% vs GFAI's -53.2%
VRRM ranks third and is worth considering specifically for growth exposure and sleep-well-at-night.
- Rev growth 11.4%, EPS growth 347.4%, 3Y rev CAGR 9.7%
- Lower volatility, beta 0.60, Low D/E 13.0%, current ratio 2.09x
- 11.4% revenue growth vs GFAI's 0.2%
- Beta 0.60 vs GFAI's 2.31
Among these 5 stocks, ARMK doesn't own a clear edge in any measured category.
ALLE carries the broadest edge in this set and is the clearest fit for income & stability and defensive.
- Dividend streak 12 yrs, beta 0.67, yield 1.5%
- Beta 0.67, yield 1.5%, current ratio 1.84x
- 15.2% margin vs GFAI's -32.9%
- 1.5% yield, 12-year raise streak, vs BCO's 0.9%, (2 stocks pay no dividend)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 11.4% revenue growth vs GFAI's 0.2% | |
| Value | Lower P/E (11.7x vs 15.6x), PEG 0.20 vs 0.92 | |
| Quality / Margins | 15.2% margin vs GFAI's -32.9% | |
| Stability / Safety | Beta 0.60 vs GFAI's 2.31 | |
| Dividends | 1.5% yield, 12-year raise streak, vs BCO's 0.9%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +19.4% vs GFAI's -53.2% | |
| Efficiency (ROA) | 12.3% ROA vs GFAI's -50.2%, ROIC 18.1% vs -41.6% |
GFAI vs BCO vs VRRM vs ARMK vs ALLE — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
GFAI vs BCO vs VRRM vs ARMK vs ALLE — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
GFAI leads in 1 of 6 categories
ARMK leads 1 • ALLE leads 1 • BCO leads 0 • VRRM leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — VRRM and ALLE each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ARMK is the larger business by revenue, generating $18.8B annually — 259.4x GFAI's $72M. ALLE is the more profitable business, keeping 15.2% of every revenue dollar as net income compared to GFAI's -32.9%. On growth, BCO holds the edge at +10.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $72M | $5.4B | $979M | $18.8B | $4.2B |
| EBITDAEarnings before interest/tax | -$12M | $797M | $351M | $1.3B | $959M |
| Net IncomeAfter-tax profit | -$24M | $180M | $131M | $317M | $634M |
| Free Cash FlowCash after capex | -$6M | $544M | $104M | $257M | $704M |
| Gross MarginGross profit ÷ Revenue | +15.1% | +26.1% | +97.5% | +7.0% | +45.0% |
| Operating MarginEBIT ÷ Revenue | -27.4% | +10.7% | +23.8% | +4.2% | +20.6% |
| Net MarginNet income ÷ Revenue | -32.9% | +3.3% | +13.4% | +1.7% | +15.2% |
| FCF MarginFCF ÷ Revenue | -8.8% | +10.1% | +10.7% | +1.4% | +16.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +3.6% | +10.3% | +0.1% | +6.1% | +9.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +38.9% | -35.3% | -15.0% | -7.7% | -7.0% |
Valuation Metrics
GFAI leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 17.2x trailing earnings, VRRM trades at a 53% valuation discount to ARMK's 36.9x P/E. Adjusting for growth (PEG ratio), BCO offers better value at 0.38x vs ALLE's 1.08x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $10M | $4.4B | $2.2B | $11.8B | $11.8B |
| Enterprise ValueMkt cap + debt − cash | -$9M | $7.1B | $2.2B | $16.9B | $13.7B |
| Trailing P/EPrice ÷ TTM EPS | -0.89x | 22.93x | 17.21x | 36.93x | 18.39x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 11.73x | 10.82x | 20.26x | 15.60x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.38x | — | — | 1.08x |
| EV / EBITDAEnterprise value multiple | — | 8.01x | 6.19x | 13.35x | 13.83x |
| Price / SalesMarket cap ÷ Revenue | 0.28x | 0.84x | 2.27x | 0.64x | 2.89x |
| Price / BookPrice ÷ Book value/share | 0.16x | 11.14x | 8.05x | 3.81x | 5.72x |
| Price / FCFMarket cap ÷ FCF | — | 10.17x | 16.26x | 26.06x | 17.14x |
Profitability & Efficiency
Evenly matched — VRRM and ALLE each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
BCO delivers a 45.6% return on equity — every $100 of shareholder capital generates $46 in annual profit, vs $-70 for GFAI. GFAI carries lower financial leverage with a 0.08x debt-to-equity ratio, signaling a more conservative balance sheet compared to BCO's 12.10x. On the Piotroski fundamental quality scale (0–9), VRRM scores 8/9 vs ALLE's 6/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -69.7% | +45.6% | +39.7% | +9.8% | +32.1% |
| ROA (TTM)Return on assets | -50.2% | +2.5% | +7.7% | +2.4% | +12.3% |
| ROICReturn on invested capital | -41.6% | +14.3% | +23.5% | +7.3% | +18.1% |
| ROCEReturn on capital employed | -19.1% | +12.1% | +16.7% | +8.7% | +20.8% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 6 | 8 | 7 | 6 |
| Debt / EquityFinancial leverage | 0.08x | 12.10x | 0.13x | 1.81x | 1.10x |
| Net DebtTotal debt minus cash | -$19M | $2.7B | -$27M | $5.1B | $1.9B |
| Cash & Equiv.Liquid assets | $22M | $2.3B | $65M | $639M | $356M |
| Total DebtShort + long-term debt | $3M | $4.9B | $38M | $5.7B | $2.3B |
| Interest CoverageEBIT ÷ Interest expense | -167.24x | 3.90x | 3.13x | 2.20x | 8.61x |
Total Returns (Dividends Reinvested)
ARMK leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ARMK five years ago would be worth $17,052 today (with dividends reinvested), compared to $46 for GFAI. Over the past 12 months, BCO leads with a +19.4% total return vs GFAI's -53.2%. The 3-year compound annual growth rate (CAGR) favors ARMK at 23.3% vs GFAI's -60.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -26.3% | -7.3% | -34.5% | +23.5% | -14.6% |
| 1-Year ReturnPast 12 months | -53.2% | +19.4% | -34.1% | +19.0% | -1.0% |
| 3-Year ReturnCumulative with dividends | -93.8% | +75.3% | -15.8% | +87.4% | +32.6% |
| 5-Year ReturnCumulative with dividends | -99.5% | +39.3% | +0.8% | +70.5% | +3.2% |
| 10-Year ReturnCumulative with dividends | -99.5% | +293.0% | +46.3% | +97.1% | +127.3% |
| CAGR (3Y)Annualised 3-year return | -60.4% | +20.6% | -5.6% | +23.3% | +9.9% |
Risk & Volatility
Evenly matched — VRRM and ARMK each lead in 1 of 2 comparable metrics.
Risk & Volatility
VRRM is the less volatile stock with a 0.60 beta — it tends to amplify market swings less than GFAI's 2.31 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ARMK currently trades 96.1% from its 52-week high vs GFAI's 31.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.31x | 1.10x | 0.60x | 0.71x | 0.67x |
| 52-Week HighHighest price in past year | $1.50 | $136.37 | $25.83 | $46.88 | $183.11 |
| 52-Week LowLowest price in past year | $0.38 | $80.10 | $13.02 | $35.07 | $131.25 |
| % of 52W HighCurrent price vs 52-week peak | +31.5% | +79.0% | +56.6% | +96.1% | +74.7% |
| RSI (14)Momentum oscillator 0–100 | 47.0 | 52.0 | 36.1 | 62.0 | 38.5 |
| Avg Volume (50D)Average daily shares traded | 378K | 543K | 1.6M | 2.2M | 887K |
Analyst Outlook
ALLE leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: BCO as "Buy", VRRM as "Buy", ARMK as "Buy", ALLE as "Hold". Consensus price targets imply 64.0% upside for VRRM (target: $24) vs 4.7% for ARMK (target: $47). For income investors, ALLE offers the higher dividend yield at 1.48% vs ARMK's 0.92%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | — | $163.00 | $24.00 | $47.20 | $172.50 |
| # AnalystsCovering analysts | — | 9 | 11 | 24 | 23 |
| Dividend YieldAnnual dividend ÷ price | — | +0.9% | — | +0.9% | +1.5% |
| Dividend StreakConsecutive years of raises | — | 6 | 2 | 1 | 12 |
| Dividend / ShareAnnual DPS | — | $1.00 | — | $0.41 | $2.03 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +4.7% | 0.0% | +1.2% | +0.7% |
GFAI leads in 1 of 6 categories (Valuation Metrics). ARMK leads in 1 (Total Returns). 3 tied.
GFAI vs BCO vs VRRM vs ARMK vs ALLE: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is GFAI or BCO or VRRM or ARMK or ALLE a better buy right now?
For growth investors, Verra Mobility Corporation (VRRM) is the stronger pick with 11.
4% revenue growth year-over-year, versus 0. 2% for Guardforce AI Co. , Limited (GFAI). Verra Mobility Corporation (VRRM) offers the better valuation at 17. 2x trailing P/E (10. 8x forward), making it the more compelling value choice. Analysts rate The Brink's Company (BCO) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — GFAI or BCO or VRRM or ARMK or ALLE?
On trailing P/E, Verra Mobility Corporation (VRRM) is the cheapest at 17.
2x versus Aramark at 36. 9x. On forward P/E, Verra Mobility Corporation is actually cheaper at 10. 8x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: The Brink's Company wins at 0. 20x versus Allegion plc's 0. 92x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — GFAI or BCO or VRRM or ARMK or ALLE?
Over the past 5 years, Aramark (ARMK) delivered a total return of +70.
5%, compared to -99. 5% for Guardforce AI Co. , Limited (GFAI). Over 10 years, the gap is even starker: BCO returned +293. 0% versus GFAI's -99. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — GFAI or BCO or VRRM or ARMK or ALLE?
By beta (market sensitivity over 5 years), Verra Mobility Corporation (VRRM) is the lower-risk stock at 0.
60β versus Guardforce AI Co. , Limited's 2. 31β — meaning GFAI is approximately 285% more volatile than VRRM relative to the S&P 500. On balance sheet safety, Guardforce AI Co. , Limited (GFAI) carries a lower debt/equity ratio of 8% versus 12% for The Brink's Company — giving it more financial flexibility in a downturn.
05Which is growing faster — GFAI or BCO or VRRM or ARMK or ALLE?
By revenue growth (latest reported year), Verra Mobility Corporation (VRRM) is pulling ahead at 11.
4% versus 0. 2% for Guardforce AI Co. , Limited (GFAI). On earnings-per-share growth, the picture is similar: Verra Mobility Corporation grew EPS 347. 4% year-over-year, compared to 9. 1% for Allegion plc. Over a 3-year CAGR, ARMK leads at 10. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — GFAI or BCO or VRRM or ARMK or ALLE?
Allegion plc (ALLE) is the more profitable company, earning 15.
8% net margin versus -16. 1% for Guardforce AI Co. , Limited — meaning it keeps 15. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VRRM leads at 24. 4% versus -18. 5% for GFAI. At the gross margin level — before operating expenses — VRRM leads at 96. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is GFAI or BCO or VRRM or ARMK or ALLE more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, The Brink's Company (BCO) is the more undervalued stock at a PEG of 0. 20x versus Allegion plc's 0. 92x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Verra Mobility Corporation (VRRM) trades at 10. 8x forward P/E versus 20. 3x for Aramark — 9. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for VRRM: 64. 0% to $24. 00.
08Which pays a better dividend — GFAI or BCO or VRRM or ARMK or ALLE?
In this comparison, ALLE (1.
5% yield), BCO (0. 9% yield), ARMK (0. 9% yield) pay a dividend. GFAI, VRRM do not pay a meaningful dividend and should not be held primarily for income.
09Is GFAI or BCO or VRRM or ARMK or ALLE better for a retirement portfolio?
For long-horizon retirement investors, Allegion plc (ALLE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
67), 1. 5% yield, +127. 3% 10Y return). Guardforce AI Co. , Limited (GFAI) carries a higher beta of 2. 31 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ALLE: +127. 3%, GFAI: -99. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between GFAI and BCO and VRRM and ARMK and ALLE?
These companies operate in different sectors (GFAI (Industrials) and BCO (Industrials) and VRRM (Technology) and ARMK (Industrials) and ALLE (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: GFAI is a small-cap quality compounder stock; BCO is a small-cap quality compounder stock; VRRM is a small-cap deep-value stock; ARMK is a mid-cap quality compounder stock; ALLE is a mid-cap quality compounder stock. BCO, ARMK, ALLE pay a dividend while GFAI, VRRM do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.